Electromed develops, manufactures, and markets innovative airway clearance devices that help people around the world breathe better, stay healthier, and lead active and fulfilling lives.
Our SmartVest Airway Clearance System is uniquely designed to make HFCWO therapy easier and more comfortable to promote consistent therapy adherence.
We embrace the absolute therapeutic imperative of clearing excess mucus from the lungs. We listen intently to users, caregivers, and healthcare professionals alike to gain insights and inspiration for future product and service innovations that improve quality of life.
Each of our products is designed, engineered, and manufactured in Minnesota, a state widely known as a global leader in medical device innovation.
Introduced first portable HFCWO device
Created first machine-washable vest garment
Invented the first programmable HFCWO vest
Developed the first multi-positional generator
Designed the industry’s smallest, quietest, and lightest generator
Launched wireless connectivity and patient communication platform
We are committed to helping those living with bronchiectasis or impaired airway clearance through innovation and outstanding customer service.
A leader in transforming organizations through product innovation, quality initiatives, and improved productivity.
An advocate of a strategic vision to increase long-term shareholder value through responsible fiscal planning and reporting.
An innovator and strategic leader who engages with others to improve and create new service opportunities.
An experienced sales leader with an accomplished history of developing high performing teams and executing growth strategies.
As a leading chest percussion device, SmartVest is featured in the press for its innovative technologies and dedication to helping people with impaired airway clearance.
The homecare distribution channel expands physician and patient access to the SmartVest in certain areas of the United States and broadens exposure of the SmartVest brand.
The study demonstrated stability of lung function post algorithm-based treatment, suggesting early initiation of high frequency chest wall oscillation (HFCWO) therapy may slow the otherwise normal progression of non-CF bronchiectasis.
Bud Reeves has joined the Company as Vice President of Sales and will oversee all domestic sales initiatives to accelerate revenue growth.
Recognized for professional achievements, leadership, and contributions to the broader Twin Cities community, Kathleen Skarvan was honored with a 2018 Women in Business award.
Long-term use of Electromed’s SmartVest Airway Clearance System reduces bronchiectasis-related exacerbations and improves patients’ quality of life, a recent study shows.
Electromed Inc. has formed a bronchiectasis advisory board composed of three renowned experts in pulmonary medicine, according to a company announcement.
We’re always on the lookout for talented professionals to join our team of patient-centered employees.
SmartVest is thoughtfully designed to make therapy easier and promote adherence.
CA 2,357,737, 2,541,333, 2,609,063, 2,712,704; DE 602007050125.3, 602008047083.0; HK 1145625; IN 292251; IT 502016000131300, 502017000060742; JP 6030218, 5155329, 5327653, 6310528; MX 341650; ZA 2006/9351, 2009/02798; KR 1471233, 1892924; ES 07861771.9, 08836173.8; TW I428123; GB 2081625, 2200556; US 6,254,556, 6,676,614, 7,278,978, 7,537,575, 7,713,219, 7,736,324, 7,770,479, 8,197,428, 8,202,237, 8,740,824, 9,289,350, 10,016,335, D531,728, D547,718, D585,991, D639,954, D697,197, D742,013
Additional patents may be pending in the U.S. and elsewhere.
The Electromed Investor Portal contains the latest financial information, events, presentations, corporate governance documents, and other investor relations services.